RE: Synairgen tweet5 Jan 2022 14:19
I think Dr Mary is just saying he wants to see the results as soon as possible, as we all do.
If you remember HR was use in the Phase 2 results and will be in the Phase 3 also:
"Patients who received SNG001 were more than twice as likely to recover (defined as
‘no limitation of activities’ or ‘no clinical or virological evidence of infection’) over the
course of the treatment period compared to those receiving placebo (HR 2.19 [95% CI
1.03-4.69]; p=0.043). "
,